問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberV940-013
Not yet recruiting

2025-09-30 - 2033-12-31

Phase II

Recruiting6

ICD-10C34.10

Malignant neoplasm of upper lobe, unspecified bronchus or lung

ICD-10C34.11

Malignant neoplasm of upper lobe, right bronchus or lung

ICD-10C34.12

Malignant neoplasm of upper lobe, left bronchus or lung

ICD-10C7A.090

Malignant carcinoid tumor of the bronchus and lung

ICD-10Z51.12

Encounter for antineoplastic immunotherapy

ICD-9162.3

Malignant neoplasm of upper lobe, bronchus or lung

  • Trial Applicant

    Merck Sharp & Dohme (I.A.) LLC

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/05/01

Investigators and Locations

Principal Investigator James Chih-Hsin Yang

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Chien-Chung Lin

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 蘇健

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Te-Chun Hsia

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    30 participants

  • Global

    180 participants